Pathway Bioventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
IpiNovyx Bioipinovyx.comSep 2021
IpiNovyx Bio is a biotech company developing potent and selective immunoproteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases.
BiotechHealthtechMedical DevicesWest Nyack, US
Marc Appel(Executive Officer, Director)Lutz Giebel(Director)James Graham(Director)Gang Lin(Scientific Founder)Carl Nathan(Scientific Founder)Franck Barrat(Scientific Founder)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.